Skip to content
HowShorted

PETMED EXPRESS INC short interest in 2020

In 2020, PETMED EXPRESS INC's disclosed short interest ran from 30.71% of shares outstanding on 15 Jan 2020 to 33.05% on 31 Dec 2020, a change of +2.34 percentage points. The year's high was 34.07% on 31 Jul 2020 and its low 20.81% on 30 Apr 2020, averaging 28.61% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.13 days on 30 Nov 2020. Full history: PETMED EXPRESS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for PETMED EXPRESS INC in 2020

2020 in figures

Start of year
30.71% (15 Jan 2020)
End of year
33.05% (31 Dec 2020)
Change
+2.34 pp
High
34.07% (31 Jul 2020)
Low
20.81% (30 Apr 2020)
Average
28.61%
Highest days to cover
17.13 (30 Nov 2020)
SEC filings marked
10

Every report in 2020

PETMED EXPRESS INC short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202030.71%14.27
31 Jan 202029.27%10.7810-Q filed
14 Feb 202028.63%13.81
28 Feb 202026.09%9.72
13 Mar 202023.96%9.82
31 Mar 202021.80%5.91
15 Apr 202023.14%8.61
30 Apr 202020.81%7.88
15 May 202026.53%8.10results (8-K), results (8-K)
29 May 202027.86%10.6710-K filed
15 Jun 202030.06%9.88
30 Jun 202031.52%11.05
15 Jul 202030.43%12.16
31 Jul 202034.07%4.87results (8-K), results (8-K)
14 Aug 202029.55%9.8710-Q filed
31 Aug 202028.58%11.04
15 Sep 202028.79%10.81
30 Sep 202031.06%14.97
15 Oct 202031.26%14.96
30 Oct 202028.60%11.00results (8-K), results (8-K)
13 Nov 202029.56%12.7810-Q filed
30 Nov 202031.20%17.13
15 Dec 202030.15%16.47
31 Dec 202033.05%12.43

See also: PETMED EXPRESS INC's full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.